Costello, P., et al., "Human cerebral endothelium: Isolation and characterization of cells derived from microvessels of non-neoplastic and malignant glial tissue", J. Neuro-Oncology, vol. 8, pp. 231-243 (1990). |
Pintus, C., et al., "Endothelial Cell Growth Supplement: a Cell Cloning Factor that Promotes the Growth of Monoclonal Antibody Producing Hybridoma Cells", Journal of Immunological Methods, vol. 61, pp. 195-200 (1983). |
Ramotar, K., et al., "Characterization of Shiga-like toxin I B subunit purified from overproducing clones of the SLT-I B cistron", Biochem. J., vol. 272, pp. 805-811 (1990). |
Rutka, J.T., et al., "Characterization of Normal Human Brain Cultures", Laboratory Investigation, vol. 55, No. 1, p. 71 (1986). |
Sandvig, K., et al., "Toxin-Induced Cell Lysis: Protection by 3-Methyladenine and Cycloheximide", Experimental Cell Research, vol. 200, pp. 253-262 (1992). |
Farkas-Himsley, et al: "Bacterial Proteinaceous Products (Bacteriocins) as Cytotoxic Agents of Neoplasia" Cancer Research 36, 3562-3567 (Oct. 1976). |
Hill, et al: "Further Studies of the Action of a Partially Purified Bacteriocin against a Murine Fibrosarcoma" Cancer Research, 51, 1359-1365 (Mar. 1, 1991). |
Karmali: "Infection by Verocytotoxin-Producing Escherichia coli", Clinical Microbiology Reviews, Jan., 1989 pp. 15-38, vol. 2, No. 1. |
Riley, et al: "Hemorrhagic Colitis Associated witha a Rare Escherichia Coli Serotype", The New England Journal of Medicine, vol. 308, No. 12, 681-685 (Mar. 24, 1983). |
Lingwood: "Verotoxins and Their Glycolipid Receptors", Advances in Lipid Research, vol. 25, 189-211 (1993). |
Van De Kar, et al: "Tumor Necrosis Factor and Interleukin-1 Induce Expression of the Verocytotoxin Receptor Globotriaosylceramide on Human Endothelial Cells: Implications for the Pathogenesis of the Hemolytic Uremic Syndrome", Blood, vol. 80, No. 11, (Dec. 1, 1992) pp. 2755-2764. |
Orbig, et al: "Endothelial Heterogeneity inShiga Toxin Receptors and Responses", The Journal of Biological Chemistry, vol. 268, No. 21, Jul. 25, 1993, pp. 15484-15488. |
Lingwood: "Verotoxin-Binding in Human Renal Sections", Nephron 1994; 66; 21-28. |
Cohen, et al: "Expression of Glycolipid Receptors to Shiga-like Toxin on Human B Lymphocytes: a Mechanism for the failure of long-lived antibody response to dysenteric disease", International Immunology, vol. 2, No. 1, 1990, pp. 1-8. |
Gregory, et al: "Identificatioof a Subset of Normal B Cells with a Burkitt's Lymphoma (BL)-like Phenotype" The Journal of Immunology, vol. 139, No. 1, (Jul. 1, 1987) pp. 313-318. |
Maloney, et al: "CD19 has a Potential CD77 (Globotriaosyl Ceramide)-binding Site with Sequence Similarity to Verotoxin B-subunits: Implications of Molecular Mimicry for B Cell Adhesion and Enterochemorrhagic Escherichia Coli Pathogenesis", J. Exp. Med. vol. 180 (Jul. 1994) 191-201. |
Maloney, et al: "Interaction of Verotoxins with Glycosphingolipids", Trends in Glycoscience and Glycotechnology vol. 5, No. 21 (Jan. 1993) pp. 23-31. |
Li, et al: "Accumlation of Globotriaosylceramide in a case of Leiomyosarcoma", Biochemistry J. (1986) vol. 240, 925-927. |
Mannori, et al: "Role of Glycolipids in the Metastatic Process: Characteristics of Neutral Glycolipids in Clones with Different Metastatic Potentials Isolated from a Murine Fibrosarcome Cell Line", Int. J. Cancer vol. 45, (1990) pp. 984-988. |
Ohyama, et al: "Changes in Clycolipid Expression in Human Testicular Tumor", Int. J. Cancer, vol. 45, (1990) pp. 1040-1044. |
Naiki, et al: "Human Erythrocyte P and P.sup.k Blood Group Antigens: Identification as Glycosphingolipids" Biochemical and Biophysical Research Communications, vol. 60, No. 3, 1974--1105-1111. |
Pallesen, et al: Distribution of the Burkitt's Lymphoma-associated Antigen (BLA) in Normal Human Tissue and Malignant Lymphoma as Defined by Immunohistological Staining with Monoclonal Antibody 38.13* J Cancer Res Clin Oncol (1987) 113: pp. 67-86. |
Kasai, et al: "Tissue Distribution of the P.sup.k Antigen as Determined by a Monoclonal Antibody", Journal of Immunogenetics (1985) vol. 12, pp. 213-220. |
Pudymaitis, et al: "Susceptibility to Verotoxin as a Function of the Cell Cycle", Journal of Cellular Physiology, 150: (1992) pp. 632-639. |
Lingwood, "Glycolipid Modificationof .alpha.2 Interferon Binding", Biochem, J. vol. 283, (1992) pp. 25-26. |
Sandvig, et al: "Retrograde Transport of Endocytossed Shiga Toxin to the Endoplasmic Reticulum", Nature vol. 358, (Aug. 6, 1992) pp. 510-512. |
Head, S.C. et al., FEMS Microbiology Letters , 51:211-16, 1988. |
Mangeney, M. et al., Cancer Research , 53: 5314-19, 1993. |